Zusammenfassung
Die Bildung von Streptolysin-S durch den Streptococcus haemolyticus wird durch Zugabe von Nucleinsäure gesteigert. Die hemmende Wirkung von hämolysierenden Streptokokken auf Ehrlich-Ascitescarcinom und Yoshida-Ascitessarkom ist dadurch zu erklären, daß die Keime auf Kosten der in den Tumorzellen enthaltenen Ribonucleinsäure Streptolysin bilden. Anderen Keimen (s. Tabelle 2) fehlt diese Eigenschaft. Auf einschlägige alte Beobachtungen an Menschen wird hingewiesen.
Da chemische Stoffe, welche die Hämolysin-S-Bildung durch Streptokokken vermindern oder gar aufheben, dies dadurch tun, daß sie in den auch für das Wachstum der Tumorzellen wichtigen Ribonucleinsäure-Stoffwechsel eingreifen, wurde unter derartigen Stoffen nach anticancerös wirkenden Mitteln gesucht und ein sehr wirksames (Azo 106) gefunden.
References
Greenstein, J. P., and A. Haddow: Advances in cancer research, vol. 1–4. New York: Academic Press 1953–1956.
Greenstein, J. P.: Biochemistry of cancer, 2. edit. New York: Academic Press 1954.
Okamoto, H.: Über die hochgradige Steigerung des Hämolysinbildungsvermögens des Streptococcus haemolyticus durch Nucleinsäure. I. Mitt. Jap. J. med. Sci., IV. Pharmacol. 12, 167 (1940).
Bernheimer, A. W., and M. Rodbart: The effect of nucleic acids and of carbohydrates on the formation of streptolysin. J. exp. Med. 88, 149 (1948).
Bernheimer, A. W.: Formation of a bacterial toxin (Streptolysin S) by resting cells. J. exp. Med. 90, 373 (1949).
Bernheimer, A. W.: Stabilization of Streptolysin S by potassium ions. J. exp. Med. 92, 129 (1950).
Cinader, B., and L. Pillemer: The purification and properties of Streptolysin S. J. exp. Med. 92, 219 (1950).
Hosoya, S., T. Hayashi, Y. Mori, F. Egami, M. Shimomura and Y. Yagi: The hemolysin obtained from the nucleic acid added broth culture of hemolytic streptococci. Jap. J. exp. Med. 20, 25 (1949).
Hosoya, S., T. Hayashi, Y. Homma, F. Egami, M. Shimomura and Y. Yagi: The hemolysin obtained by shaking a mixture of hemolytic streptococci with nucleic acid solution. Jap. J. exp. Med. 20, 27 (1949).
Egami, F., M. Shimomura, Y. Yagi, T. Hayashi, T. Mase and S. Hosoya: The hemolysin obtained by incubating a mixture of hemolytic streptococci with nucleic acid solution. Jap. J. exp. Med. 20, 527 (1950).
Okamoto, H., S. Kyoda u. R. Ito: Weitere Ergebnisse der Untersuchung zur Darstellung hochgereinigter Streptolysinpräparate. Jap. J. med. Sci., IV. Pharmacol. 14, 99 (1941).
Okamoto, H., K. Matsuda, u. S. Kyoda: Chemische Untersuchungen an hochgereinigter Streptolysinfraktion. Folia pharmacol. jap. 33, 370 (1941).
Matsuda, K.: Untersuchungen über die pharmakologischen Eigenschaften des Streptolysin. Folia pharmacol. jap. 36, 171 (1942).
Shimizu, R.: Studies on the capability of yeast ribonucleic acid to transfer silver salt into a non-ionized form. J. pharmaceut. Soc. Jap. 76, 158 (1956).
Shoin, S.: On the stabilizing effect of silver salts upon Streptolysin S. Jap. J. exp. Med. 24, 13 (1954).
Tanaka, K., S. Maekawa, T. Hayashi and Y. Kuroiwa: Effects of alkali-treated ribonucleic acid in the hemolysin formation. J. Biochem. (Tokyo) 43, 827 (1956).
Tanaka, K., S. Maekawa and T. Hayashi: Effects of ribonuclease digestion of ribonucleic acid on the hemolysin formation. J. Biochem. (Tokyo) 43, 833 (1956).
Younathan, E. S., and S. S. Barkulis: Effect of some antimetabolites on the production of streptolysin. J. Bact. 74, 151 (1957).
McCarty, M.: Streptococcal infections. Columbia University Press 1954.
Okamoto, H.: A study on the phenomenon of the high promotion by nucleic acid of the production of streptococcal hemolysin, streptolysin S. Symp. Soc. Cell. Chem. 3, 145 (1954).
Bernheimer, A. W.: Properties of certain rapidly acting bacterial toxins as illustrated by streptolysins O and S. Bact. Rev. 12, 195 (1948).
Ito, R., T. Okami and M. Yoshimura: On the production of streptolysin by resting hemolytic streptococci suspended in nucleic acid solution. Jap. med. J. 1, 253 (1948).
Bernheimer, A. W., J. E. Winter, P. J. Ortiz, S. Ochoa, F. Egami, K. Tanaka, T. Hayashi and S. Mii: Induction of streptolysin formation by biosynthetic polyribonucleotides. Biochim. biophys. Acta (1957).
Ito, R.: Über die spezifische entgiftende Wirkung der Farbstoffe der Trypanblaureihe auf das Streptolysin. Folia pharmacol. jap. 30, 20 (1940).
Rosendal, K., and A. W. Bernheimer: Paradoxical effect of congo red on the toxicity of streptolysin S for mice. J. Immunol. 68, 53 (1952).
Miyaji, T.: Studies on the mode of anti-streptolysin S action of trypan blue. Ann. R. Tbc. (Kanazawa) 11 (3), 237 (1953).
Ito, R., T. Okami, M. Yoshimura and S. Sagara: The inhibition of the production of hemolytic toxin of Streptococcus pyogenes by 0,0′-dihydroxyazobenzene and related compounds. Jap. med. J. 1, 260 (1948).
Himeno, Y.: Experiments on the influence of various derivatives in the dihydroxyazobenzene series upon the production of streptolysin S by Streptococcus hemolyticus in the resting cell system. Ann. R. Tbc. (Kanazawa) 12 (2), 111 (1954).
Koshimura, S., R. Shimizu, T. Masusaki, T. Ohta and G. Kishi: On the formation of streptolysin S by acting hemolytic streptococci on tumor cells. Jap. J. Microbiol. 2 No 1 (1958).
Hirata, R.: Experimental anticancer studies. Part I. The preparation of 6-(2′-hydroxy-3′,5′-dibromophenylazo)-4-hexylresorcinol and related compounds, with brief reference to their anticancer activity. Pharm. Bull. (Tôkyô) 4, 60 (1956).
Koshimura, S., K. Murasawa, E. Nakagawa, M. Ueda, Y. Bando and R. Hirata: Experimental anticancer studies. Part II. On the anti-tumor effect of 6-(2′-hydroxy-3′,5′-dihalophenylazo)-4-hexylresorcinol and related compounds on Yoshida sarcoma and Ehrlich ascites carcinoma in vivo. Gann 47, 393 (1956).
Koshimura, S., K. Murasawa, E. Nakagawa, M. Ueda, Y. Bando and R. Hirata: Experimental anticancer studies. Part III. On the influence of living hemolytic streptococci upon the invasion power of Ehrlich ascites carcinoma in mice. Jap. J. exp. Med. 25, 93 (1955).
Koshimura, S., K. Murasawa, M. Ueda, Y. Bando, R. Hirata, T. Ohta and M. Ishikawa: Experimental anticancer studies. Part IV. On the influence of hydroxybenzylidene-, phenoxazone- and quinone-derivatives, and various compounds on Yoshida sarcoma in rat. Gann 47, 391 (1956).
Hirata, R.: Experimental anticancer studies. Part V. Bis(2-hydroxy-3,5-dibromophenylazo)-alkylphloroglucinols and their inhibitory effect against Ehrlich ascites carcinoma in mice. Jap. J. exp. Med. 27, 99 (1957).
Ohta, T.: Experimental anticancer studies. Part VI. Experiments on the influence of living A group hemolytic streptococci and several other species of microorganisms on the invasion power of Ehrlich carcinoma cells to mice. Jap. J. exp. Med. 27, 107 (1957).
Busch, E.: Berl. klin. Wschr. 1866, 245.
Fehleisen: Über die Züchtung der Erysipelkokken auf künstlichem Nährboden und ihre Übertragbarkeit auf den Menschen. Dtsch. med. Wschr. 1882, 553.
Bruns, P.: Die Heilwirkung des Erysipelas auf Geschwülste. Bruns' Beitr. klin. Chir. 3, 443 (1888).
The detailed data will be published in the near future.
Author information
Authors and Affiliations
Additional information
With 3 textfigures
Rights and permissions
About this article
Cite this article
Okamoto, H., Koshimura, S., Hirata, R. et al. Some data in anti-cancer experiments. Z Krebs-forsch 62, 408–418 (1958). https://doi.org/10.1007/BF00528009
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00528009